Oral Leukoplakia: Etiology, Diagnosis, Clinical Features and Treatment

What Is Oral Leukoplakia?

Leukoplakia is a chronic condition affecting mucous membranes, most commonly in the oral cavity. Characterized by excessive keratinization and inflammation, it is considered a facultative precancerous condition. Early diagnosis and management are critical, as leukoplakia carries a risk of malignant transformation.

Need a clearer framework for diagnosing white and potentially malignant oral lesions? Learn how to recognize leukoplakia, differentiate it from other oral findings, and build a sound diagnostic approach with Dr. Ashley Clark, a diplomate of the American Board of Oral and Maxillofacial Pathology, in “Library of Oral Pathology: Management of Precancerous and Cancerous Oral Lesions”.

The definition of leukoplakia given by the World Health Organization (WHO) is "white patches or plaques that cannot be scraped off with an instrument during examination." These lesions can be different in size, they have different shape variations, and consistency and usually cannot be removed by mechanical means. This condition is primarily a protective reaction of the mucosa, but at the same time leukoplakia is a marker of potential malignant transformation.

The onset of leukoplakia is not associated with any specific causative organism and represents a diagnosis of exclusion. This makes detailed examination and histopathological analysis essential in determining its nature and progression.

Leukoplakia should be approached as a clinical diagnosis of exclusion rather than a generic label for any white oral lesion, because frictional keratosis, smokeless tobacco keratosis, and other known white lesions are not classified the same way and do not carry the same diagnostic implications.

In this video, Dr. Ashley Clark explains how to recognize true leukoplakia clinically, why sharply demarcated white plaques require biopsy, how thin leukoplakia can progress into thick, verruciform, and erythroleukoplakic forms, and why red-and-white lesions may indicate more advanced dysplasia or even squamous cell carcinoma.

Etiology of Leukoplakia

Although the precise cause of leukoplakia remains unclear, it is widely believed to result from prolonged exposure to irritants. External factors include mechanical irritation from dental issues (e.g., sharp teeth, ill-fitting dentures, protruding fillings), consumption of hot or spicy foods, alcohol, and chemical exposure in occupational settings. Endogenous contributors include metabolic disorders, hormonal imbalances, and deficiencies in vitamins such as vitamin A.

Industrial exposures, such as high-voltage electrical fields and chemicals in industries like coking, iodine mining, and electrolysis, are also linked to its development. Furthermore, hereditary or congenital predisposition is not entirely ruled out.

Risk Factors of Leukoplakia

Several risk factors contribute to the development of leukoplakia:

• Tobacco Use: Both smoking and chewing tobacco are major contributors. Smoking introduces polycyclic hydrocarbons, leading to mechanical, thermal, and chemical trauma to the mucosa.
• Alcohol Consumption: Strong alcoholic beverages exacerbate mucosal irritation and may act synergistically with tobacco.
• Mechanical Trauma: Chronic irritation caused by dental appliances, sharp fillings, or biting habits.
• Occupational Hazards: Exposure to dyes, tar, phenols, and formaldehyde.
• Systemic Illnesses: Conditions like diabetes, HIV, and tuberculosis.
• Nutritional Deficiencies: Particularly in vitamins A and B.
• Genetic Predisposition: Hereditary factors may increase susceptibility to mucosal keratinization.

Pathogenesis of Leukoplakia

Leukoplakia develops as a keratotic response to chronic irritation. The condition is characterized by varying degrees of thickening of the epithelial layer. The submucosal tissue is usually involved. There are such inflammatory changes as the loosening and destruction of elastic fibers. The formation of an inflammatory infiltrate composed of lymphocytes and plasma cells can alternate with sites of fibrosis and sclerosis. These inflammatory changes may sometimes be minimal or absent, with more noticeable alterations occurring in the epithelium. There may be areas of keratinization where it is not supposed to be found, or keratin layer on keratinized epithelial patches is thicker than it normally is. The main disturbances are found in the third (granular) layer of the epithelium, where keratohyalin and intermediate filaments are present. Pathological changes include hyperkeratosis (thickened keratin layer), parakeratosis (retained nuclei in keratinized cells), and acanthosis (thickened epithelial layers). These alterations are often accompanied by submucosal inflammation, fibrosis, and vascular changes, all of which reflects a protective response against external stressors. 

Clinical Features of Leukoplakia

The clinical features of leukoplakia largely depend on where they are found in the oral cavity. The most common sites are the oral mucosa, the soft and hard palates, front sections of cheeks, top of the tongue and its sides, and the floor of the mouth. Typically, leukoplakia starts as a clouding of the mucous membrane, with lesions that are characteristic of smokers. 

The most common form is flat leukoplakia and it often isn’t a cause of any noticeable symptoms, though there may be a sensation of tightness. The primary morphological feature is a spot, an irregular, clouded area of epithelium with clear borders.

When leukoplakia occurs, patients may experience discomfort, burning sensations, or pain, especially if the integrity of the epithelium is compromised. Ulcers, cracks, and erosions can form on the surface, leading to pain, which intensifies with mechanical, chemical, or thermal irritation. This is especially true for erosions or ulcers on the gums or tongue.

Because leukoplakia is a chronic condition, patients often have difficulty recalling when symptoms first appeared. It is only when the integrity of the epithelium is broken that patients can more clearly pinpoint when the discomfort, burning, or pain started. Upon examination, poor oral hygiene is often noted, which can exacerbate the condition.

Leukoplakia manifests in various forms, each with distinct features:

1. Flat (Simple) Leukoplakia:

   • Asymptomatic, often detected incidentally.
   • Appears as thin, white patches with smooth surfaces.

2. Verrucous Leukoplakia:

   • Arises from flat leukoplakia due to chronic irritation.
   • Features raised, pearly, wart-like plaques with clear or irregular edges, rough surfaces, resembling a callus.
   • Patients may complain of roughness or protrusion of the mucous membrane. Sometimes, there may be a loss of taste if the tongue is affected.

3. Erosive-ulcerative Leukoplakia:

   • Characterized by erosions, cracks, and ulcers.
   • Painful, especially during eating or mechanical irritation.

4. Hairy Leukoplakia:

   • It is a precancerous dysplastic condition associated with Epstein-Barr virus in conjunction with the human papillomavirus, and occurs in individuals with significant immune system deficiencies, such as those with HIV/AIDS.
   • Presented as raised grayish-white patches up to 2-3 cm in size, with well-defined borders and a rough, villous surface.
   • It is particularly prone to malignant transformation when located on the floor of the mouth, under the tongue, or on the palate and lips

5. Tobacco-Related Leukoplakia (Leukoplakia Associated with Smoking):

   • Linked to tobacco use, with wrinkled or smooth white patches.
   • Reversible upon smoking cessation in early stages.

6. Erythroplakia:

   • Features pale white lesions with bright red patches due to increased vascularization of the subepithelial connective tissue without significant hyperkeratosis.
   • Red plaques that protrude on limited areas of the mucous membrane, often with uneven contours.
   • High risk of malignancy.

7. Leukoedema:

   • Milky-white opalescent patches, this form is often found in the mucous membrane of the lips or soft palate and is typically bilateral.
   • More pronounced in smokers and regresses upon cessation.
   • Histologically, it shows thickening of the epithelium with swelling of the cells in the spinous layer, without signs of inflammation.

Diagnosis and Differential Diagnosis of Oral Leukoplakia

Diagnosis involves a thorough examination, patient history, and identification of risk factors. Key diagnostic tools include:

1. Visual Inspection: Identification of white lesions that cannot be scraped off.
2. Palpation: Assessing lesion consistency and surrounding mucosa.
3. Biopsy: Histopathological analysis to determine dysplasia or malignancy.
4. Differential Diagnosis: Distinguishing leukoplakia from conditions like lichen planus, candidiasis, or aphthous ulcers.
5. Advanced Imaging and Biomarkers: Tools like toluidine blue staining and fluorescence visualization can aid in detecting areas of dysplasia or malignancy.

Treatment Options for Leukoplakia

Treatment depends on the form and severity of leukoplakia:

1. Elimination of Irritants:

   • Discontinuing smoking and alcohol.
   • Addressing dental issues (e.g., replacing sharp fillings).

2. Medical Management:

   • Topical retinoids to normalize keratinization.
   • Antifungal treatment if Candida infection is present.
   • Use of anti-inflammatory agents to reduce irritation.

3. Surgical Interventions:

   • Excision or laser ablation for advanced lesions.
   • Cryotherapy for localized lesions.

4. Regular Monitoring:

   • Follow-up to detect malignant transformation early.

Prevention of Leukoplakia

Preventive measures include:

• Avoiding tobacco and alcohol.
• Maintaining proper oral hygiene.
• Using protective equipment in hazardous occupations.
• Regular dental check-ups for early detection.
• Balanced nutrition to prevent deficiencies.

Additionally, education about risk factors and encouraging behavioral changes are vital components of public health strategies to reduce the incidence of leukoplakia.

Leukoplakia is a significant clinical condition requiring timely diagnosis and management due to its potential for cancerous transformation. A multidisciplinary approach involving dentists, pathologists, and oncologists ensures effective treatment and monitoring. Public health measures focusing on education and prevention can substantially reduce the prevalence and impact of leukoplakia.

The integration of modern diagnostic tools and therapeutic advancements offers promising avenues to mitigate the risks associated with leukoplakia. Early intervention and continued research remain pivotal in improving outcomes for affected individuals.